Prevention and Longevity

Ageing goes hand in hand with increased oxidative damage to cells leading toward cellular decline and organ dysfunction. Indeed, Schriner et al. (2005) have shown that an increase in antioxidant defence in the mitochondria, the main producer of reactive oxygen species, extend life. Most importantly ageing is associated with specific diseases that we attempt to address only after their onset. However, as for everything, prevention is often the best course of action. Yamamoto et al (2021) highlight this and advocate for the preventative use of molecular hydrogen against pre-symptomatic diseases.

One core example is immunosenescence brought about by chronic inflammation and a chronic pro-inflammatory state. Most, if not all, degenerative and age-related diseases can be linked to mitochondrial dysfunction and associated elevated oxidative stress. Molecular hydrogen promotes mitochondrial function by increasing ATP production and influencing metabolic pathways away from glycolysis and toward oxidative phosphorylation.

Molecular hydrogen’s antioxidant, anti-inflammatory and immuno-restorative action is documented and lacks deleterious side effects, making it a prime candidate for the preventive treatment of pre-symptomatic diseases. Because H2 diffuse rapidly in the organism reaching every mitochondrion in the body molecular hydrogen can act as a protectant to all pre-symptomatic diseases at the same time and indiscriminately before the onset of symptoms.